DNA Methylation Markers for Breast Cancer Detection in the Developing World
Abstract
An unmet need in low-resource countries is an automated breast cancer detection assay to prioritize women who should undergo core breast biopsy and pathologic review. Therefore, we sought to identify and validate a panel of methylated DNA markers to discriminate between cancer and benign breast lesions using cells obtained by fine-needle aspiration (FNA).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 01, 2019
- Source ID
- 10.1158/1078-0432.ccr-18-3277
Entities
People
- Andrea Richardson
- Antonio C. Wolff
- Ashley Cimino-mathews
- Bradley M. Downs
- Brian Rhees
- Christopher B Umbricht
- Chuang Chen
- Claudia Mercado-rodriguez
- Danielle Meir-levi
- Edward Gabrielson
- Edwin W. Lai
- Eunice Van Den Berg
- Fernando Schmitt
- Gary M. Tse
- Jing-ping Yuan
- Juanjuan Li
- Kala Visvanathan
- Kriszten J. Kocmond
- Leslie M. Cope
- Marina B. Mosunjac
- Mary Jo Fackler
- Michael Bates
- Monica Rizzo
- Rupali Sood
- Saraswati Sukumar
- Susan C. Harvey
- Suzana Tulac
- Syed Z. Ali
- Timothy De Guzman
Organizations
- Avon Foundation for Women
- Emory University
- Emory University School of Medicine
- Johns Hopkins School of Medicine
- Johns Hopkins University
- The Chinese University of Hong Kong
- United States Department of Defense
- University of Porto
- Wuhan University
- Wuhan University People's Hospital